Skip to content
HowShorted

MYRIAD GENETICS INC short interest in 2024

In 2024, MYRIAD GENETICS INC's disclosed short interest ran from 4.65% of shares outstanding on 12 Jan 2024 to 5.25% on 31 Dec 2024, a change of +0.60 percentage points. The year's high was 7.24% on 30 Apr 2024 and its low 3.68% on 13 Dec 2024, averaging 5.05% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 9.94 days on 28 Mar 2024. Full history: MYRIAD GENETICS INC.

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for MYRIAD GENETICS INC in 2024

2024 in figures

Start of year
4.65% (12 Jan 2024)
End of year
5.25% (31 Dec 2024)
Change
+0.60 pp
High
7.24% (30 Apr 2024)
Low
3.68% (13 Dec 2024)
Average
5.05%
Highest days to cover
9.94 (28 Mar 2024)
SEC filings marked
10

Every report in 2024

MYRIAD GENETICS INC short interest in 2024
SettlementShort interestDays to coverFilings since previous
12 Jan 20244.65%5.62
31 Jan 20244.51%6.41results (8-K)
15 Feb 20244.50%6.39
29 Feb 20244.87%6.02results (8-K), 10-K filed
15 Mar 20245.84%6.28
28 Mar 20246.89%9.94
15 Apr 20246.69%9.94
30 Apr 20247.24%9.62
15 May 20245.63%4.38results (8-K), 10-Q filed
31 May 20245.31%8.34
14 Jun 20246.73%8.30
28 Jun 20245.10%4.67
15 Jul 20244.24%5.37
31 Jul 20244.85%4.99
15 Aug 20244.27%4.71results (8-K), 10-Q filed
30 Aug 20244.34%7.53
13 Sep 20244.34%5.36
30 Sep 20244.61%5.70
15 Oct 20244.95%7.08results (8-K)
31 Oct 20244.94%9.34
15 Nov 20244.06%2.63results (8-K), 10-Q filed
29 Nov 20243.72%4.07
13 Dec 20243.68%3.12
31 Dec 20245.25%4.56

See also: MYRIAD GENETICS INC's full history · most shorted US stocks of 2024 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.